Share Price and Basic Stock Data
Last Updated: January 22, 2026, 11:47 pm
| PEG Ratio | 4.56 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Mastek Ltd, operating in the IT Consulting and Software industry, reported a market capitalization of ₹6,740 Cr and a share price of ₹2,175. The company has exhibited a robust revenue growth trajectory, with sales rising from ₹2,184 Cr in FY 2022 to ₹2,563 Cr in FY 2023, marking an increase of 17.4%. For FY 2024, sales further escalated to ₹3,055 Cr, and the trailing twelve months (TTM) revenue stands at ₹3,630 Cr. Quarterly sales data reflects this upward trend, with the most recent quarter (Sep 2023) reporting sales of ₹766 Cr, up from ₹709 Cr in Mar 2023. This consistent growth in revenue, coupled with a reported operating profit margin (OPM) of 15%, illustrates Mastek’s ability to leverage its service offerings effectively in a competitive market. The company’s strategic focus on digital transformation and cloud services has likely contributed to this revenue enhancement, positioning it well within a sector that is increasingly prioritizing these solutions.
Profitability and Efficiency Metrics
Mastek’s profitability metrics reveal a stable performance, with a net profit of ₹365 Cr for the most recent fiscal year, reflecting a marginal decline from ₹310 Cr in FY 2023. The company’s return on equity (ROE) stood at 16.1%, while the return on capital employed (ROCE) recorded at 17.3% indicates efficient capital utilization. However, the operating profit margin has shown some fluctuation, recorded at 18% in FY 2023 but declining to 16% in the latest quarter. Quarterly net profits have also varied, with a peak of ₹129 Cr in Sep 2024, demonstrating strong profitability during this period. Mastek’s interest coverage ratio (ICR) at 13.52x reflects its strong ability to meet interest obligations, which is favorable for maintaining investor confidence. These metrics highlight a solid operational framework, although the slight decrease in margins necessitates close monitoring to ensure sustained profitability amid rising operational costs.
Balance Sheet Strength and Financial Ratios
Mastek’s balance sheet exhibits a healthy financial structure, with total assets reported at ₹4,034 Cr and total borrowings of ₹544 Cr, leading to a low debt-to-equity ratio of 0.22x. The company has also reported reserves of ₹2,661 Cr, indicating a strong equity base to support future growth initiatives. The current and quick ratios are both at 1.95x, demonstrating ample liquidity to cover short-term obligations. Furthermore, the price-to-book value ratio (P/BV) stands at 2.74x, suggesting that the stock is trading at a premium relative to its book value, which can be indicative of strong market confidence in Mastek’s future prospects. The strong equity capital of ₹15 Cr alongside retained earnings showcases Mastek’s commitment to reinvestment and growth. Despite these strengths, the company must navigate potential risks associated with its high operational costs and market volatility, which could impact future financial stability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Mastek Ltd reveals a diversified ownership structure, with promoters holding 35.79% of the shares, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold 11.24% and 11.52%, respectively. The public holds a significant 41.45% stake, indicating broad market participation and interest in the company. Over recent quarters, promoter shareholding has slightly declined from 37.27% in Dec 2022 to the current 35.79%, suggesting a gradual dilution of control. Conversely, the proportion of FIIs has stabilized around 11% after peaking at 14.10% in Dec 2023, reflecting cautious optimism among foreign investors. The number of shareholders stands at 1,00,780, which indicates a stable investor base. This diverse ownership structure coupled with a reasonable level of institutional interest suggests confidence in Mastek’s operational strategy and growth potential, although the declining promoter stake may warrant attention from investors regarding long-term governance.
Outlook, Risks, and Final Insight
Mastek Ltd is positioned favorably for future growth, driven by its strong revenue generation capabilities and robust balance sheet. However, the company faces several risks, including fluctuations in operating margins and potential increases in operational costs that could pressure profitability. Additionally, a decline in promoter shareholding could raise concerns about governance and control among investors. If Mastek can effectively manage its operational efficiency and maintain its competitive edge in the rapidly evolving IT landscape, it may continue to attract investor interest. Conversely, failure to adapt to market changes or manage costs could hinder growth prospects. Overall, while Mastek’s fundamentals are sound, ongoing monitoring of both internal and external factors will be essential for sustaining its growth trajectory and enhancing shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | / | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 60.2 Cr. | 19.0 | 21.0/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 118 Cr. | 109 | 194/99.8 | 18.0 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 45.8 Cr. | 357 | 359/140 | 28.6 | 26.7 | 0.28 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 5.99 Cr. | 1.11 | 1.73/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Industry Average | 20,312.58 Cr | 532.81 | 80.30 | 123.69 | 0.59% | 14.88% | 20.92% | 6.84 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 625 | 659 | 709 | 725 | 766 | 784 | 780 | 813 | 867 | 870 | 905 | 915 | 940 |
| Expenses | 518 | 545 | 584 | 598 | 642 | 651 | 655 | 689 | 724 | 729 | 767 | 777 | 795 |
| Operating Profit | 107 | 114 | 126 | 127 | 123 | 134 | 125 | 124 | 143 | 141 | 139 | 137 | 146 |
| OPM % | 17% | 17% | 18% | 18% | 16% | 17% | 16% | 15% | 16% | 16% | 15% | 15% | 15% |
| Other Income | 32 | 6 | -0 | 2 | 1 | 3 | 5 | 4 | 17 | 13 | -5 | 11 | 15 |
| Interest | 5 | 8 | 9 | 9 | 13 | 13 | 9 | 9 | 11 | 12 | 10 | 9 | 9 |
| Depreciation | 17 | 20 | 20 | 20 | 21 | 22 | 27 | 20 | 20 | 17 | 19 | 18 | 18 |
| Profit before tax | 117 | 92 | 96 | 100 | 90 | 102 | 94 | 99 | 129 | 126 | 106 | 121 | 134 |
| Tax % | 27% | 27% | 25% | 27% | 28% | 24% | -1% | 28% | 0% | 25% | 23% | 24% | 27% |
| Net Profit | 86 | 67 | 73 | 74 | 65 | 78 | 94 | 72 | 129 | 95 | 81 | 92 | 97 |
| EPS in Rs | 26.30 | 21.33 | 23.77 | 22.91 | 20.50 | 24.56 | 29.85 | 23.18 | 41.68 | 30.67 | 26.20 | 29.75 | 31.46 |
Last Updated: December 30, 2025, 12:37 am
Below is a detailed analysis of the quarterly data for Mastek Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 940.00 Cr.. The value appears strong and on an upward trend. It has increased from 915.00 Cr. (Jun 2025) to 940.00 Cr., marking an increase of 25.00 Cr..
- For Expenses, as of Sep 2025, the value is 795.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 777.00 Cr. (Jun 2025) to 795.00 Cr., marking an increase of 18.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 146.00 Cr.. The value appears strong and on an upward trend. It has increased from 137.00 Cr. (Jun 2025) to 146.00 Cr., marking an increase of 9.00 Cr..
- For OPM %, as of Sep 2025, the value is 15.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 15.00%.
- For Other Income, as of Sep 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Jun 2025) to 15.00 Cr., marking an increase of 4.00 Cr..
- For Interest, as of Sep 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 9.00 Cr..
- For Depreciation, as of Sep 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 18.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 134.00 Cr.. The value appears strong and on an upward trend. It has increased from 121.00 Cr. (Jun 2025) to 134.00 Cr., marking an increase of 13.00 Cr..
- For Tax %, as of Sep 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Jun 2025) to 27.00%, marking an increase of 3.00%.
- For Net Profit, as of Sep 2025, the value is 97.00 Cr.. The value appears strong and on an upward trend. It has increased from 92.00 Cr. (Jun 2025) to 97.00 Cr., marking an increase of 5.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 31.46. The value appears strong and on an upward trend. It has increased from 29.75 (Jun 2025) to 31.46, marking an increase of 1.71.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:59 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 923 | 1,013 | 527 | 560 | 817 | 1,033 | 1,071 | 1,722 | 2,184 | 2,563 | 3,055 | 3,455 | 3,630 |
| Expenses | 833 | 965 | 509 | 515 | 718 | 902 | 916 | 1,357 | 1,721 | 2,108 | 2,546 | 2,909 | 3,068 |
| Operating Profit | 90 | 47 | 18 | 45 | 100 | 132 | 156 | 364 | 463 | 456 | 509 | 546 | 562 |
| OPM % | 10% | 5% | 3% | 8% | 12% | 13% | 15% | 21% | 21% | 18% | 17% | 16% | 15% |
| Other Income | 11 | 14 | 15 | 12 | 21 | 25 | 17 | 28 | 36 | 64 | 12 | 30 | 35 |
| Interest | 1 | 1 | 0 | 4 | 6 | 6 | 4 | 8 | 8 | 25 | 44 | 42 | 39 |
| Depreciation | 33 | 37 | 16 | 15 | 19 | 17 | 25 | 45 | 43 | 67 | 90 | 75 | 72 |
| Profit before tax | 68 | 22 | 16 | 39 | 96 | 133 | 144 | 339 | 448 | 427 | 386 | 459 | 486 |
| Tax % | 24% | 20% | 17% | 17% | 27% | 24% | 21% | 26% | 26% | 27% | 19% | 18% | |
| Net Profit | 52 | 18 | 14 | 32 | 70 | 101 | 114 | 252 | 333 | 310 | 311 | 376 | 365 |
| EPS in Rs | 23.37 | 7.86 | 5.97 | 13.86 | 29.53 | 42.33 | 44.82 | 82.97 | 98.32 | 95.99 | 97.36 | 121.50 | 118.08 |
| Dividend Payout % | 19% | 32% | 42% | 25% | 20% | 20% | 18% | 17% | 19% | 20% | 20% | 19% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -65.38% | -22.22% | 128.57% | 118.75% | 44.29% | 12.87% | 121.05% | 32.14% | -6.91% | 0.32% | 20.90% |
| Change in YoY Net Profit Growth (%) | 0.00% | 43.16% | 150.79% | -9.82% | -74.46% | -31.41% | 108.18% | -88.91% | -39.05% | 7.23% | 20.58% |
Mastek Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 26% |
| 3 Years: | 17% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 25% |
| 3 Years: | 9% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 29% |
| 3 Years: | 11% |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 20% |
| 3 Years: | 17% |
| Last Year: | 16% |
Last Updated: Unknown
Balance Sheet
Last Updated: December 4, 2025, 1:38 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 12 | 12 | 12 | 12 | 12 | 13 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 549 | 585 | 308 | 457 | 537 | 704 | 778 | 846 | 1,056 | 1,668 | 2,072 | 2,447 | 2,661 |
| Borrowings | 2 | 29 | 0 | 66 | 70 | 70 | 335 | 273 | 203 | 404 | 519 | 583 | 544 |
| Other Liabilities | 192 | 207 | 108 | 170 | 202 | 179 | 763 | 1,146 | 1,193 | 1,024 | 1,045 | 803 | 813 |
| Total Liabilities | 754 | 832 | 428 | 705 | 821 | 966 | 1,888 | 2,277 | 2,467 | 3,111 | 3,652 | 3,848 | 4,034 |
| Fixed Assets | 261 | 279 | 66 | 180 | 179 | 167 | 857 | 807 | 841 | 1,740 | 1,950 | 1,818 | 1,846 |
| CWIP | 0 | 1 | 0 | 0 | 2 | 1 | 2 | 2 | 4 | 7 | 1 | 2 | 2 |
| Investments | 84 | 54 | 50 | 274 | 284 | 396 | 276 | 234 | 26 | 69 | 94 | 178 | 188 |
| Other Assets | 409 | 498 | 312 | 251 | 356 | 401 | 754 | 1,235 | 1,596 | 1,296 | 1,607 | 1,851 | 1,998 |
| Total Assets | 754 | 832 | 428 | 705 | 821 | 966 | 1,888 | 2,277 | 2,467 | 3,111 | 3,652 | 3,848 | 4,034 |
Below is a detailed analysis of the balance sheet data for Mastek Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 15.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,661.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,447.00 Cr. (Mar 2025) to 2,661.00 Cr., marking an increase of 214.00 Cr..
- For Borrowings, as of Sep 2025, the value is 544.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 583.00 Cr. (Mar 2025) to 544.00 Cr., marking a decrease of 39.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 813.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 803.00 Cr. (Mar 2025) to 813.00 Cr., marking an increase of 10.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 4,034.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,848.00 Cr. (Mar 2025) to 4,034.00 Cr., marking an increase of 186.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,846.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,818.00 Cr. (Mar 2025) to 1,846.00 Cr., marking an increase of 28.00 Cr..
- For CWIP, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Investments, as of Sep 2025, the value is 188.00 Cr.. The value appears strong and on an upward trend. It has increased from 178.00 Cr. (Mar 2025) to 188.00 Cr., marking an increase of 10.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,998.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,851.00 Cr. (Mar 2025) to 1,998.00 Cr., marking an increase of 147.00 Cr..
- For Total Assets, as of Sep 2025, the value is 4,034.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,848.00 Cr. (Mar 2025) to 4,034.00 Cr., marking an increase of 186.00 Cr..
Notably, the Reserves (2,661.00 Cr.) exceed the Borrowings (544.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 88.00 | 18.00 | 18.00 | -21.00 | 30.00 | 62.00 | -179.00 | 91.00 | 260.00 | 52.00 | -10.00 | -37.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 46 | 48 | 67 | 55 | 78 | 74 | 108 | 79 | 73 | 72 | 67 | 78 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 46 | 48 | 67 | 55 | 78 | 74 | 108 | 79 | 73 | 72 | 67 | 78 |
| Working Capital Days | 26 | 25 | 38 | 29 | 15 | 38 | 4 | -35 | -20 | 34 | -1 | 28 |
| ROCE % | 12% | 5% | 3% | 10% | 17% | 19% | 16% | 26% | 32% | 23% | 18% | 17% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Tata Digital India Fund | 680,894 | 1.25 | 150.73 | 155,070 | 2025-12-08 01:19:52 | 339.09% |
| Bandhan Small Cap Fund | 322,058 | 0.39 | 71.29 | N/A | N/A | N/A |
| Bandhan Large & Mid Cap Fund | 292,295 | 0.51 | 64.71 | 206,982 | 2025-12-15 01:56:50 | 41.22% |
| ICICI Prudential Technology Fund | 232,734 | 0.33 | 51.52 | 250,560 | 2025-12-08 01:19:52 | -7.11% |
| ICICI Prudential Multicap Fund | 84,674 | 0.12 | 18.74 | N/A | N/A | N/A |
| WhiteOak Capital Flexi Cap Fund | 69,640 | 0.22 | 15.42 | N/A | N/A | N/A |
| ICICI Prudential Retirement Fund - Pure Equity | 26,288 | 0.37 | 5.82 | N/A | N/A | N/A |
| LIC MF Small Cap Fund | 24,509 | 0.88 | 5.43 | N/A | N/A | N/A |
| LIC MF Value Fund | 11,823 | 1.28 | 2.62 | 12,360 | 2025-12-15 01:56:50 | -4.34% |
| WhiteOak Capital ELSS Tax Saver Fund | 4,742 | 0.23 | 1.05 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 121.78 | 98.01 | 97.23 | 106.52 | 84.92 |
| Diluted EPS (Rs.) | 120.65 | 97.25 | 95.53 | 106.52 | 81.88 |
| Cash EPS (Rs.) | 145.78 | 129.99 | 123.74 | 125.35 | 117.55 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 795.84 | 676.85 | 581.42 | 406.96 | 336.32 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 795.84 | 676.85 | 581.42 | 406.96 | 336.32 |
| Revenue From Operations / Share (Rs.) | 1116.75 | 990.53 | 839.90 | 727.46 | 682.19 |
| PBDIT / Share (Rs.) | 183.82 | 170.13 | 161.91 | 166.09 | 155.46 |
| PBIT / Share (Rs.) | 159.54 | 140.98 | 139.83 | 151.81 | 137.65 |
| PBT / Share (Rs.) | 148.40 | 125.22 | 140.03 | 149.25 | 134.44 |
| Net Profit / Share (Rs.) | 121.50 | 100.83 | 101.66 | 111.07 | 99.74 |
| NP After MI And SOA / Share (Rs.) | 121.50 | 97.37 | 96.01 | 98.31 | 82.94 |
| PBDIT Margin (%) | 16.45 | 17.17 | 19.27 | 22.83 | 22.78 |
| PBIT Margin (%) | 14.28 | 14.23 | 16.64 | 20.86 | 20.17 |
| PBT Margin (%) | 13.28 | 12.64 | 16.67 | 20.51 | 19.70 |
| Net Profit Margin (%) | 10.88 | 10.17 | 12.10 | 15.26 | 14.62 |
| NP After MI And SOA Margin (%) | 10.88 | 9.83 | 11.43 | 13.51 | 12.15 |
| Return on Networth / Equity (%) | 15.26 | 14.38 | 17.40 | 27.54 | 17.93 |
| Return on Capital Employeed (%) | 16.88 | 16.75 | 17.74 | 27.85 | 22.21 |
| Return On Assets (%) | 9.73 | 8.14 | 9.32 | 11.86 | 9.11 |
| Long Term Debt / Equity (X) | 0.15 | 0.15 | 0.15 | 0.11 | 0.16 |
| Total Debt / Equity (X) | 0.22 | 0.23 | 0.22 | 0.17 | 0.16 |
| Asset Turnover Ratio (%) | 0.91 | 0.89 | 0.18 | 0.17 | 0.16 |
| Current Ratio (X) | 1.95 | 1.42 | 1.69 | 1.78 | 1.87 |
| Quick Ratio (X) | 1.95 | 1.42 | 1.69 | 1.78 | 1.87 |
| Dividend Payout Ratio (NP) (%) | 15.60 | 19.39 | 19.59 | 16.10 | 6.50 |
| Dividend Payout Ratio (CP) (%) | 13.00 | 14.92 | 15.93 | 14.06 | 5.35 |
| Earning Retention Ratio (%) | 84.40 | 80.61 | 80.41 | 83.90 | 93.50 |
| Cash Earning Retention Ratio (%) | 87.00 | 85.08 | 84.07 | 85.94 | 94.65 |
| Interest Coverage Ratio (X) | 13.52 | 11.80 | 19.99 | 64.92 | 48.44 |
| Interest Coverage Ratio (Post Tax) (X) | 9.76 | 8.09 | 12.53 | 44.41 | 32.08 |
| Enterprise Value (Cr.) | 6839.86 | 7924.50 | 4956.73 | 9576.73 | 2360.43 |
| EV / Net Operating Revenue (X) | 1.98 | 2.59 | 1.93 | 4.39 | 1.37 |
| EV / EBITDA (X) | 12.03 | 15.10 | 10.03 | 19.21 | 6.02 |
| MarketCap / Net Operating Revenue (X) | 1.95 | 2.56 | 1.83 | 4.56 | 1.79 |
| Retention Ratios (%) | 84.39 | 80.60 | 80.40 | 83.89 | 93.49 |
| Price / BV (X) | 2.74 | 3.75 | 2.79 | 9.30 | 2.64 |
| Price / Net Operating Revenue (X) | 1.95 | 2.56 | 1.83 | 4.56 | 1.79 |
| EarningsYield | 0.05 | 0.03 | 0.06 | 0.02 | 0.06 |
After reviewing the key financial ratios for Mastek Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 121.78. This value is within the healthy range. It has increased from 98.01 (Mar 24) to 121.78, marking an increase of 23.77.
- For Diluted EPS (Rs.), as of Mar 25, the value is 120.65. This value is within the healthy range. It has increased from 97.25 (Mar 24) to 120.65, marking an increase of 23.40.
- For Cash EPS (Rs.), as of Mar 25, the value is 145.78. This value is within the healthy range. It has increased from 129.99 (Mar 24) to 145.78, marking an increase of 15.79.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 795.84. It has increased from 676.85 (Mar 24) to 795.84, marking an increase of 118.99.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 795.84. It has increased from 676.85 (Mar 24) to 795.84, marking an increase of 118.99.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,116.75. It has increased from 990.53 (Mar 24) to 1,116.75, marking an increase of 126.22.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 183.82. This value is within the healthy range. It has increased from 170.13 (Mar 24) to 183.82, marking an increase of 13.69.
- For PBIT / Share (Rs.), as of Mar 25, the value is 159.54. This value is within the healthy range. It has increased from 140.98 (Mar 24) to 159.54, marking an increase of 18.56.
- For PBT / Share (Rs.), as of Mar 25, the value is 148.40. This value is within the healthy range. It has increased from 125.22 (Mar 24) to 148.40, marking an increase of 23.18.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 121.50. This value is within the healthy range. It has increased from 100.83 (Mar 24) to 121.50, marking an increase of 20.67.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 121.50. This value is within the healthy range. It has increased from 97.37 (Mar 24) to 121.50, marking an increase of 24.13.
- For PBDIT Margin (%), as of Mar 25, the value is 16.45. This value is within the healthy range. It has decreased from 17.17 (Mar 24) to 16.45, marking a decrease of 0.72.
- For PBIT Margin (%), as of Mar 25, the value is 14.28. This value is within the healthy range. It has increased from 14.23 (Mar 24) to 14.28, marking an increase of 0.05.
- For PBT Margin (%), as of Mar 25, the value is 13.28. This value is within the healthy range. It has increased from 12.64 (Mar 24) to 13.28, marking an increase of 0.64.
- For Net Profit Margin (%), as of Mar 25, the value is 10.88. This value exceeds the healthy maximum of 10. It has increased from 10.17 (Mar 24) to 10.88, marking an increase of 0.71.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.88. This value is within the healthy range. It has increased from 9.83 (Mar 24) to 10.88, marking an increase of 1.05.
- For Return on Networth / Equity (%), as of Mar 25, the value is 15.26. This value is within the healthy range. It has increased from 14.38 (Mar 24) to 15.26, marking an increase of 0.88.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.88. This value is within the healthy range. It has increased from 16.75 (Mar 24) to 16.88, marking an increase of 0.13.
- For Return On Assets (%), as of Mar 25, the value is 9.73. This value is within the healthy range. It has increased from 8.14 (Mar 24) to 9.73, marking an increase of 1.59.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.15.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 0.23 (Mar 24) to 0.22, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.91. It has increased from 0.89 (Mar 24) to 0.91, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has increased from 1.42 (Mar 24) to 1.95, marking an increase of 0.53.
- For Quick Ratio (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has increased from 1.42 (Mar 24) to 1.95, marking an increase of 0.53.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 15.60. This value is below the healthy minimum of 20. It has decreased from 19.39 (Mar 24) to 15.60, marking a decrease of 3.79.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 13.00. This value is below the healthy minimum of 20. It has decreased from 14.92 (Mar 24) to 13.00, marking a decrease of 1.92.
- For Earning Retention Ratio (%), as of Mar 25, the value is 84.40. This value exceeds the healthy maximum of 70. It has increased from 80.61 (Mar 24) to 84.40, marking an increase of 3.79.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 87.00. This value exceeds the healthy maximum of 70. It has increased from 85.08 (Mar 24) to 87.00, marking an increase of 1.92.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 13.52. This value is within the healthy range. It has increased from 11.80 (Mar 24) to 13.52, marking an increase of 1.72.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.76. This value is within the healthy range. It has increased from 8.09 (Mar 24) to 9.76, marking an increase of 1.67.
- For Enterprise Value (Cr.), as of Mar 25, the value is 6,839.86. It has decreased from 7,924.50 (Mar 24) to 6,839.86, marking a decrease of 1,084.64.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.98. This value is within the healthy range. It has decreased from 2.59 (Mar 24) to 1.98, marking a decrease of 0.61.
- For EV / EBITDA (X), as of Mar 25, the value is 12.03. This value is within the healthy range. It has decreased from 15.10 (Mar 24) to 12.03, marking a decrease of 3.07.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has decreased from 2.56 (Mar 24) to 1.95, marking a decrease of 0.61.
- For Retention Ratios (%), as of Mar 25, the value is 84.39. This value exceeds the healthy maximum of 70. It has increased from 80.60 (Mar 24) to 84.39, marking an increase of 3.79.
- For Price / BV (X), as of Mar 25, the value is 2.74. This value is within the healthy range. It has decreased from 3.75 (Mar 24) to 2.74, marking a decrease of 1.01.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has decreased from 2.56 (Mar 24) to 1.95, marking a decrease of 0.61.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mastek Ltd:
- Net Profit Margin: 10.88%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.88% (Industry Average ROCE: 14.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15.26% (Industry Average ROE: 20.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 9.76
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.95
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 17 (Industry average Stock P/E: 80.3)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.22
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.88%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | 804/805, President House, Opp. C N Vidyalaya, Ahmedabad Gujarat 380006 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashank Desai | Chairman, Non Ind & Non Exe Director |
| Mr. Umang Nahata | WholeTime Director & CEO |
| Mr. Ketan Mehta | Non Exe.Non Ind.Director |
| Mr. Suresh Vaswani | Ind. Non-Executive Director |
| Mr. Rajeev Kumar Grover | Ind. Non-Executive Director |
| Ms. Marilyn Jones | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Mastek Ltd?
Mastek Ltd's intrinsic value (as of 23 January 2026) is ₹1983.79 which is 6.03% lower the current market price of ₹2,111.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹6,543 Cr. market cap, FY2025-2026 high/low of ₹2,818/1,883, reserves of ₹2,661 Cr, and liabilities of ₹4,034 Cr.
What is the Market Cap of Mastek Ltd?
The Market Cap of Mastek Ltd is 6,543 Cr..
What is the current Stock Price of Mastek Ltd as on 23 January 2026?
The current stock price of Mastek Ltd as on 23 January 2026 is ₹2,111.
What is the High / Low of Mastek Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Mastek Ltd stocks is ₹2,818/1,883.
What is the Stock P/E of Mastek Ltd?
The Stock P/E of Mastek Ltd is 17.0.
What is the Book Value of Mastek Ltd?
The Book Value of Mastek Ltd is 864.
What is the Dividend Yield of Mastek Ltd?
The Dividend Yield of Mastek Ltd is 1.09 %.
What is the ROCE of Mastek Ltd?
The ROCE of Mastek Ltd is 17.3 %.
What is the ROE of Mastek Ltd?
The ROE of Mastek Ltd is 16.1 %.
What is the Face Value of Mastek Ltd?
The Face Value of Mastek Ltd is 5.00.